![](https://hatalab.mgh.harvard.edu/wp-content/uploads/2019/10/IDJ-JTO-2019-thumbnail.jpg)
J Thorac Oncol – 2019 Oct – PMID: 31558234
Dagogo-Jack I, Cobb R, Banwait M, Lennerz JK, Hata AN, Digumarthy SR, Sequist LV. Response to the Combination of Osimertinib and Trametinib in a Patient With EGFR-Mutant NSCLC Harboring an Acquired BRAF Fusion. J Thorac Oncol. 2019 Oct;14(10):e226-e228. PMID: 31558234